Last reviewed · How we verify

NCT03984526

Atropine or Ephedrine Pretreatment for Preventing Bradycardia in Elderly Patients

Completed Phase 4 Last updated 4 February 2021
What this trial tests

Phase 4 trial testing normal saline in Anesthesia, Spinal in 102 participants. Completed in 15 September 2020.

Timeline
25 June 2019
Primary endpoint
15 September 2020
15 September 2020

Quick facts

Lead sponsorAjou University School of Medicine
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment102
Start date25 June 2019
Primary completion15 September 2020
Estimated completion15 September 2020
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Ajou University School of Medicine

Who can join

Adults 65 to 100, any sex, with Anesthesia, Spinal or Dexmedetomidine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Spinal anesthesia is widely used for lower extremity surgery, and sedation is often required during surgery. For sedation, propofol, midazolam and dexmedetomidine are frequently used. Dexmedetomidine is a highly selective alpha 2 receptor agonist, and has sedating and analgesic effect. Compared with propofol and midazolam, it has little or no respiratory inhibition and hemodynamically stable. It also has the effect of reducing delirium in the elderly. Dexmedetomidine has also been reported to prolong the duration of sensory and motor blockade effects of spinal anesthesia. However, several studies have reported that administration of dexmedetomidine in spinal anesthesia increases the incidence of bradycardia. In a study of healthy young adults, concurrent administration of atropine with dexmedetomidine in spinal anesthesia significantly reduced the frequency of bradycardia requiring treatment. However, in elderly patients, it is often reported that there is little response to atropine in bradycardia, and ephedrine is more effective in treating bradycardia than atropine in the elderly. The investigators therefore compared ephedrine and atropine as pretreatment to reduce the incidence of bradycardia when using dexmedetomidine as a sedative in elderly patients undergoing spinal anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of normal saline

Trials testing the same drug.

Other recruiting trials for Anesthesia, Spinal

Currently open trials in the same condition.

Other Ajou University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03984526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing